Acadia Pharmaceuticals (ACAD) Change in Intangibles (2025)
Acadia Pharmaceuticals (ACAD) recorded quarterly Change in Intangibles of $98.8 million in Q1 2025.
Acadia Pharmaceuticals (ACAD) Change in Intangibles (2025) Analysis & Trends
Acadia Pharmaceuticals' Change in Intangibles history runs 1 years deep, the most recent figure standing at $98.8 million for Q1 2025.
- In Q1 2025, Change in Intangibles changed N/A year-over-year to $98.8 million; the TTM figure through Dec 2025 stood at $98.8 million (changed N/A YoY), while the FY2025 annual figure was $98.8 million, changed N/A from the prior year.
- Change in Intangibles was $98.8 million for Q1 2025 at Acadia Pharmaceuticals.
- In the past five years, Change in Intangibles ranged from a high of $98.8 million in Q1 2025 to a low of $98.8 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.96 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Acadia Pharmaceuticals | 3.68 Bn | 2.83 Bn | 243.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 98.84 Mn |
| Mar 31, 2025 | 98.84 Mn |